マーケットレポート詳細

血液検査の世界市場:2031年予測

Hematology Diagnostics Market (Product Type: Hematology Instruments and Hematology Consumables; and End-user: Diagnostic Laboratories, Hospitals & Clinics, Academic Institutes, and Others) - Global Industry Analysis, Size, Share, Volume, Growth, Trends, and Forecast, 2023-2031

出版元:Transparency Market Research   出版元について
発行年:2023年12月
定価 :Single User License(1名様ライセンス)US$5,795(米国ドル)/Multi User License(5名様)$8,795 /Enterprise License $11,705
ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。
ご請求は円換算(お見積り日TTSレート)となります。
納品形態:PDF by Email
当調査レポートは英文228ページになります。
商品コード:TMR146

お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。

【レポート紹介】

血液検査の世界市場規模は2022年で46億ドル、2031年に76億ドル、市場の平均年成長率は5.6%になると予測されています。

当レポートでは、血液検査の市場予測-2031年、各種セグメント別市場分析(製品タイプ別、エンドユーザー別、国地域別、等)、パイプライン分析、COVID-19の影響分析、主要企業プロフィールなどの情報を盛り込み、概略以下の構成でお届けいたします。

【レポート構成概要】

■血液検査の世界市場予測2023-2031年

・市場規模(US$)

■製品タイプ別、市場-2031年

血液学機器
・血球計数装置
-全自動血球計数装置
-半自動血球計数装置
・フローサイトメーター
・その他

血液学用消耗品
・試薬
・染色剤
・コントロール/キャリブレーター
・その他
※(市場規模US$)

■エンドユーザー別、市場-2031年

診断研究所
病院/クリニック
学術機関
その他
※(市場規模US$)

■主要国地域別市場-2031年

北米
・米国、カナダ
欧州
・ドイツ、英国、フランス
・イタリア、スペイン
・その他欧州
アジア太平洋
・日本、中国、インド
・オーストラリア/ニュージーランド
・その他アジア太平洋
中南米
・ブラジル、メキシコ
・その他中南米
中東アフリカ
・GCC諸国、南アフリカ
・その他中東アフリカ
※地域別に各種セグメント別の細分化データ掲載、詳細は目次参照

■市場分析

市場ダイナミクス(促進要因、障壁、機会)
パイプライン分析
COVID-19の影響分析
競合状況
市場シェア分析
SWOT分析

■血液検査の主要企業プロフィール動向

Abbott
シスメックス株式会社
F. Hoffmann-La Roche Ltd.
Beckman Coulter, Inc.
Bio-Rad Laboratories, Inc.
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
Siemens Healthineers AG
株式会社堀場製作所
HemoCue AB
Danaher Corporation

(全228頁)
【レポート詳細目次、データ項目一覧は当ページ下を参照ください】

Table of Contents (英文詳細目次)

1. Preface

    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights

2. Assumptions and Research Methodology
3. Executive Summary: Global Hematology Diagnostics Market
4. Market Overview

    4.1. Introduction
        4.1.1. Product Definition
        4.1.2. Industry Evolution/Developments
    4.2. Overview
    4.3. Market Dynamics
        4.3.1. Drivers
        4.3.2. Restraints
        4.3.3. Opportunities
    4.4. Global Hematology Diagnostics Market Analysis and Forecast, 2023–2031

5. Key Insights

    5.1. Pipeline Analysis
    5.2. Key Product/Brand Analysis
    5.3. Key Mergers & Acquisitions
    5.4. COVID-19 Pandemic Impact on Industry

6. Global Hematology Diagnostics Market Analysis and Forecast, by Product Type

    6.1. Introduction & Definition
    6.2. Key Findings/Developments
    6.3. Market Value Forecast, by Product Type, 2023–2031
        6.3.1. Hematology Instruments
            6.3.1.1. Hematology Analyzers
                6.3.1.1.1. Fully-automated Hematology Analyzers
                6.3.1.1.2. Semi-automated Hematology Analyzers
            6.3.1.2. Flow Cytometers
            6.3.1.3. Others
        6.3.2. Hematology Consumables
            6.3.2.1. Reagents
            6.3.2.2. Stains
            6.3.2.3. Controls & Calibrators
            6.3.2.4. Others
    6.4. Market Attractiveness Analysis, by Product Type

7. Global Hematology Diagnostics Market Analysis and Forecast, by End-user

    7.1. Introduction & Definition
    7.2. Key Findings/Developments
    7.3. Market Value Forecast, by End-user, 2023–2031
        7.3.1. Diagnostic Laboratories
        7.3.2. Hospitals & Clinics
        7.3.3. Academic Institutes
        7.3.4. Others
    7.4. Market Attractiveness Analysis, by End-user

8. Global Hematology Diagnostics Market Analysis and Forecast, by Region

    8.1. Key Findings
    8.2. Market Value Forecast, by Region, 2023–2031
        8.2.1. North America
        8.2.2. Europe
        8.2.3. Asia Pacific
        8.2.4. Latin America
        8.2.5. Middle East & Africa
    8.3. Market Attractiveness Analysis, by Region

9. North America Hematology Diagnostics Market Analysis and Forecast

    9.1. Introduction
    9.2. Key Findings
    9.3. Market Value Forecast, by Product Type, 2023–2031
        9.3.1. Hematology Instruments
            9.3.1.1. Hematology Analyzers
                9.3.1.1.1. Fully-automated Hematology Analyzers
                9.3.1.1.2. Semi-automated Hematology Analyzers
            9.3.1.2. Flow Cytometers
            9.3.1.3. Others
        9.3.2. Hematology Consumables
            9.3.2.1. Reagents
            9.3.2.2. Stains
            9.3.2.3. Controls & Calibrators
            9.3.2.4. Others
    9.4. Market Value Forecast, by End-user, 2023–2031
        9.4.1. Diagnostic Laboratories
        9.4.2. Hospitals & Clinics
        9.4.3. Academic Institutes
    9.5. Market Value Forecast, by Country, 2023–2031
        9.5.1. U.S.
        9.5.2. Canada
    9.6. Market Attractiveness Analysis
        9.6.1. By Product Type
        9.6.2. By End-user
        9.6.3. By Country

10. Europe Hematology Diagnostics Market Analysis and Forecast

    10.1. Introduction
    10.2. Key Findings
    10.3. Market Value Forecast, by Product Type, 2023–2031
        10.3.1. Hematology Instruments
            10.3.1.1. Hematology Analyzers
                10.3.1.1.1. Fully-automated Hematology Analyzers
                10.3.1.1.2. Semi-automated Hematology Analyzers
            10.3.1.2. Flow Cytometers
            10.3.1.3. Others
        10.3.2. Hematology Consumables
            10.3.2.1. Reagents
            10.3.2.2. Stains
            10.3.2.3. Controls & Calibrators
            10.3.2.4. Others
    10.4. Market Value Forecast, by End-user, 2023–2031
        10.4.1. Diagnostic Laboratories
        10.4.2. Hospitals & Clinics
        10.4.3. Academic Institutes
        10.4.4. Others
    10.5. Market Value Forecast, by Country/Sub-region, 2023–2031
        10.5.1. Germany
        10.5.2. U.K.
        10.5.3. France
        10.5.4. Italy
        10.5.5. Spain
        10.5.6. Rest of Europe
    10.6. Market Attractiveness Analysis
        10.6.1. By Product Type
        10.6.2. By End-user
        10.6.3. By Country/Sub-region

11. Asia Pacific Hematology Diagnostics Market Analysis and Forecast

    11.1. Introduction
    11.2. Key Findings
    11.3. Market Value Forecast, by Product Type, 2023–2031
        11.3.1. Hematology Instruments
            11.3.1.1. Hematology Analyzers
                11.3.1.1.1. Fully-automated Hematology Analyzers
                11.3.1.1.2. Semi-automated Hematology Analyzers
            11.3.1.2. Flow Cytometers
            11.3.1.3. Others
        11.3.2. Hematology Consumables
            11.3.2.1. Reagents
            11.3.2.2. Stains
            11.3.2.3. Controls & Calibrators
            11.3.2.4. Others
    11.4. Market Value Forecast, by End-user, 2023–2031
        11.4.1. Diagnostic Laboratories
        11.4.2. Hospitals & Clinics
        11.4.3. Academic Institutes
        11.4.4. Others
    11.5. Market Value Forecast, by Country/Sub-region, 2023–2031
        11.5.1. China
        11.5.2. Japan
        11.5.3. India
        11.5.4. Australia & New Zealand
        11.5.5. Rest of Asia Pacific
    11.6. Market Attractiveness Analysis
        11.6.1. By Product Type
        11.6.2. By End-user
        11.6.3. By Country/Sub-region

12. Latin America Hematology Diagnostics Market Analysis and Forecast

    12.1. Introduction
    12.2. Key Findings
    12.3. Market Value Forecast, by Product Type, 2023–2031
        12.3.1. Hematology Instruments
            12.3.1.1. Hematology Analyzers
                12.3.1.1.1. Fully-automated Hematology Analyzers
                12.3.1.1.2. Semi-automated Hematology Analyzers
            12.3.1.2. Flow Cytometers
            12.3.1.3. Others
        12.3.2. Hematology Consumables
            12.3.2.1. Reagents
            12.3.2.2. Stains
            12.3.2.3. Controls & Calibrators
            12.3.2.4. Others
    12.4. Market Value Forecast, by End-user, 2023–2031
        12.4.1. Diagnostic Laboratories
        12.4.2. Hospitals & Clinics
        12.4.3. Academic Institutes
        12.4.4. Others
    12.5. Market Value Forecast, by Country/Sub-region, 2023–2031
        12.5.1. Brazil
        12.5.2. Mexico
        12.5.3. Rest of Latin America
    12.6. Market Attractiveness Analysis
        12.6.1. By Product Type
        12.6.2. By End-user
        12.6.3. By Country/Sub-region

13. Middle East & Africa Hematology Diagnostics Market Analysis and Forecast

    13.1. Introduction
    13.2. Key Findings
    13.3. Market Value Forecast, by Product Type, 2023–2031
        13.3.1. Hematology Instruments
            13.3.1.1. Hematology Analyzers
                13.3.1.1.1. Fully-automated Hematology Analyzers
                13.3.1.1.2. Semi-automated Hematology Analyzers
            13.3.1.2. Flow Cytometers
            13.3.1.3. Others
        13.3.2. Hematology Consumables
            13.3.2.1. Reagents
            13.3.2.2. Stains
            13.3.2.3. Controls & Calibrators
            13.3.2.4. Others
    13.4. Market Value Forecast, by End-user, 2023–2031
        13.4.1. Diagnostic Laboratories
        13.4.2. Hospitals & Clinics
        13.4.3. Academic Institutes
        13.4.4. Others
    13.5. Market Value Forecast, by Country/Sub-region, 2023–2031
        13.5.1. GCC Countries
        13.5.2. South Africa
        13.5.3. Rest of Middle East & Africa
    13.6. Market Attractiveness Analysis
        13.6.1. By Product Type
        13.6.2. By End-user
        13.6.3. By Country/Sub-region

14. Competition Landscape

    14.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
    14.2. Market Share Analysis, by Company (2022)
    14.3. Company Profiles
        14.3.1. Abbott
            14.3.1.1. Company Overview
            14.3.1.2. Product Portfolio
            14.3.1.3. SWOT Analysis
            14.3.1.4. Financial Overview
            14.3.1.5. Strategic Overview
        14.3.2. Sysmex Corporation
            14.3.2.1. Company Overview
            14.3.2.2. Product Portfolio
            14.3.2.3. SWOT Analysis
            14.3.2.4. Financial Overview
            14.3.2.5. Strategic Overview
        14.3.3. F. Hoffmann-La Roche Ltd.
            14.3.3.1. Company Overview
            14.3.3.2. Product Portfolio
            14.3.3.3. SWOT Analysis
            14.3.3.4. Financial Overview
            14.3.3.5. Strategic Overview
        14.3.4. Beckman Coulter, Inc.
            14.3.4.1. Company Overview
            14.3.4.2. Product Portfolio
            14.3.4.3. SWOT Analysis
            14.3.4.4. Financial Overview
            14.3.4.5. Strategic Overview
        14.3.5. Bio-Rad Laboratories, Inc.
            14.3.5.1. Company Overview
            14.3.5.2. Product Portfolio
            14.3.5.3. SWOT Analysis
            14.3.5.4. Financial Overview
            14.3.5.5. Strategic Overview
        14.3.6. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
            14.3.6.1. Company Overview
            14.3.6.2. Product Portfolio
            14.3.6.3. SWOT Analysis
            14.3.6.4. Financial Overview
            14.3.6.5. Strategic Overview
        14.3.7. Siemens Healthineers AG
            14.3.7.1. Company Overview
            14.3.7.2. Product Portfolio
            14.3.7.3. SWOT Analysis
            14.3.7.4. Financial Overview
            14.3.7.5. Strategic Overview
        14.3.8. Horiba, Ltd.
            14.3.8.1. Company Overview
            14.3.8.2. Product Portfolio
            14.3.8.3. SWOT Analysis
            14.3.8.4. Financial Overview
            14.3.8.5. Strategic Overview
        14.3.9. HemoCue AB
            14.3.9.1. Company Overview
            14.3.9.2. Product Portfolio
            14.3.9.3. SWOT Analysis
            14.3.9.4. Financial Overview
            14.3.9.5. Strategic Overview
        14.3.10. Danaher Corporation
            14.3.10.1. Company Overview
            14.3.10.2. Product Portfolio
            14.3.10.3. SWOT Analysis
            14.3.10.4. Financial Overview
            14.3.10.5. Strategic Overview

List of Tables

Table 01: Global Hematology Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2023–2031

Table 02: Global Hematology Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2023–2031

Table 03: Global Hematology Diagnostics Market Size (US$ Mn) Forecast, by Region, 2023–2031

Table 04: North America Hematology Diagnostics Market Size (US$ Mn) Forecast, by Country, 2023–2031

Table 05: North America Hematology Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2023–2031

Table 06: North America Hematology Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2023–2031

Table 07: Europe Hematology Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2023–2031

Table 8: Europe Hematology Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2023–2031

Table 9: Europe Hematology Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2023–2031

Table 10: Asia Pacific Hematology Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2023–2031

Table 11: Asia Pacific Hematology Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2023–2031

Table 12: Asia Pacific Hematology Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2023–2031

Table 13: Latin America Hematology Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2023–2031

Table 14: Latin America Hematology Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2023–2031

Table 15: Latin America Hematology Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2023–2031

Table 16: Middle East & Africa Hematology Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2023–2031

Table 17: Middle East & Africa Hematology Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2023–2031

Table 18: Middle East & Africa Hematology Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2023–2031

List of Figures

Figure 01: Global Hematology Diagnostics Market Size (US$ Mn) and Distribution (%), by Region, 2023 and 2031

Figure 02: Global Hematology Diagnostics Market Revenue (US$ Mn), by Product Type, 2022

Figure 03: Global Hematology Diagnostics Market Value Share, by Product Type, 2022

Figure 04: Global Hematology Diagnostics Market Revenue (US$ Mn), by End-user, 2022

Figure 05: Global Hematology Diagnostics Market Value Share, by End-user, 2022

Figure 06: Global Hematology Diagnostics Market Value Share, by Region, 2022

Figure 07: Global Hematology Diagnostics Market Value (US$ Mn) Forecast, 2023–2031

Figure 8: Global Hematology Diagnostics Market Value Share Analysis, by Product Type, 2023 and 2031

Figure 9: Global Hematology Diagnostics Market Attractiveness Analysis, by Product Type, 2022-2031

Figure 10: Global Hematology Diagnostics Market Value Share Analysis, by End-user, 2023 and 2031

Figure 11: Global Hematology Diagnostics Market Attractiveness Analysis, by End-user, 2022-2031

Figure 12: Global Hematology Diagnostics Market Value Share Analysis, by Region, 2023 and 2031

Figure 13: Global Hematology Diagnostics Market Attractiveness Analysis, by Region, 2022-2031

Figure 14: North America Hematology Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2023–2031

Figure 15: North America Hematology Diagnostics Market Attractiveness Analysis, by Country, 2023–2031

Figure 16: North America Hematology Diagnostics Market Value Share Analysis, by Country, 2023 and 2031

Figure 17: North America Hematology Diagnostics Market Value Share Analysis, by Product Type, 2023 and 2031

Figure 18: North America Hematology Diagnostics Market Value Share Analysis, by End-user, 2023 and 2031

Figure 19: North America Hematology Diagnostics Market Attractiveness Analysis, by Product Type, 2022–2031

Figure 20: North America Hematology Diagnostics Market Attractiveness Analysis, by End-user, 2022–2031

Figure 21: Europe Hematology Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2023–2031

Figure 22: Europe Hematology Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 23: Europe Hematology Diagnostics Market Value Share Analysis, by Country/Sub-region, 2023 and 2031

Figure 24: Europe Hematology Diagnostics Market Value Share Analysis, by Product Type, 2023 and 2031

Figure 25: Europe Hematology Diagnostics Market Value Share Analysis, by End-user, 2023 and 2031

Figure 26: Europe Hematology Diagnostics Market Attractiveness Analysis, by Product Type, 2022–2031

Figure 27: Europe Hematology Diagnostics Market Attractiveness Analysis, by End-user, 2022–2031

Figure 28: Asia Pacific Hematology Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2023–2031

Figure 29: Asia Pacific Hematology Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 30: Asia Pacific Hematology Diagnostics Market Value Share Analysis, by Country/Sub-region, 2023 and 2031

Figure 31: Asia Pacific Hematology Diagnostics Market Value Share Analysis, by Product Type, 2023 and 2031

Figure 32: Asia Pacific Hematology Diagnostics Market Value Share Analysis, by End-user, 2023 and 2031

Figure 33: Asia Pacific Hematology Diagnostics Market Attractiveness Analysis, by Product Type, 2022–2031

Figure 34: Asia Pacific Hematology Diagnostics Market Attractiveness Analysis, by End-user, 2022–2031

Figure 35: Latin America Hematology Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2023–2031

Figure 36: Latin America Hematology Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 37: Latin America Hematology Diagnostics Market Value Share Analysis, by Country/Sub-region, 2023 and 2031

Figure 38: Latin America Hematology Diagnostics Market Value Share Analysis, by Product Type, 2023 and 2031

Figure 39: Latin America Hematology Diagnostics Market Value Share Analysis, by End-user, 2023 and 2031

Figure 40: Latin America Hematology Diagnostics Market Attractiveness Analysis, by Product Type, 2022–2031

Figure 41: Latin America Hematology Diagnostics Market Attractiveness Analysis, by End-user, 2022–2031

Figure 42: Middle East & Africa Hematology Diagnostics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2023–2031

Figure 43: Middle East & Africa Hematology Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 44: Middle East & Africa Hematology Diagnostics Market Value Share Analysis, by Country/Sub-region, 2023 and 2031

Figure 45: Middle East & Africa Hematology Diagnostics Market Value Share Analysis, by Product Type, 2023 and 2031

Figure 46: Middle East & Africa Hematology Diagnostics Market Value Share Analysis, by End-user, 2023 and 2031

Figure 47: Middle East & Africa Hematology Diagnostics Market Attractiveness Analysis, by Product Type, 2022–2031

Figure 48: Middle East & Africa Hematology Diagnostics Market Attractiveness Analysis, by End-user, 2022–2031

△ 一番上に戻る